Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Obsidian Therapeutics, Inc. (OBX)

Obsidian Therapeutics completes Galera merger and $350 million private placement

Mixed Impact 5 of 5 m&a Written later

Obsidian Therapeutics completed its mergers with Galera Therapeutics on August 3, 2026, alongside a $350 million private placement. Legacy Obsidian holders now own about 51.6% of the combined company, Galera holders about 1.2%, and private placement investors about 47.2%, so existing shareholders are substantially diluted. The filing also says the company's 2025 going concern doubt and its prior losses remain risk factors.

Key points

  • Mergers consummated at 8:30 a.m. ET on August 3, 2026; the company was renamed Obsidian Therapeutics, Inc.
  • Concurrent PIPE Financing raised $350.0 million; about 29,165,559 shares were issued to investors.
  • Post-closing ownership: Legacy Obsidian about 51.6%, Legacy Galera about 1.2%, PIPE investors about 47.2%.
  • Shares expected to begin trading on Nasdaq under OBX on August 4, 2026; CVRs issued to Galera holders of record as of July 31, 2026.

The filing

CompanyObsidian Therapeutics, Inc. (OBX)
Form8-K, current report
Filed with the SECAug 3, 2026, 5:08 PM ET
Accession number0001193125-26-330810

Items reported: 1.01 Material Definitive Agreement2.01 Acquisition or Disposition Completed2.02 Results of Operations3.02 Unregistered Equity Sale3.03 Change to Shareholder Rights4.01 Auditor Change5.01 Change in Control5.02 Director / Officer Change5.03 Bylaw / Charter Amendment7.01 Regulation FD Disclosure

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 03, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.